SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-358491
Filing Date
2021-12-16
Accepted
2021-12-16 06:08:02
Documents
13
Period of Report
2021-12-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d246741d8k.htm   iXBRL 8-K 22940
2 EX-99.1 d246741dex991.htm EX-99.1 51984
  Complete submission text file 0001193125-21-358491.txt   210537

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arwr-20211216.xsd EX-101.SCH 2920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20211216_lab.xml EX-101.LAB 18140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20211216_pre.xml EX-101.PRE 11427
6 EXTRACTED XBRL INSTANCE DOCUMENT d246741d8k_htm.xml XML 3367
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 211495937
SIC: 2834 Pharmaceutical Preparations